Vantage Consulting Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,605
Closed -$235K 90
2024
Q2
$235K Buy
1,605
+115
+8% +$17.1K 0.17% 129
2024
Q1
$236K Sell
1,490
-25
-2% -$3.98K 0.15% 150
2023
Q4
$237K Buy
1,515
+69
+5% +$10.6K 0.16% 150
2023
Q3
$225K Buy
1,446
+5
+0.3% +$825 0.15% 152
2023
Q2
$239K Sell
1,441
-137
-9% -$22.1K 0.14% 150
2023
Q1
$245K Buy
1,578
+198
+14% +$32K 0.14% 167
2022
Q4
$244K Sell
1,380
-173
-11% -$29.9K 0.14% 141
2022
Q3
$254K Buy
1,553
+156
+11% +$26.4K 0.15% 103
2022
Q2
$248K Buy
1,397
+44
+3% +$7.84K 0.14% 131
2022
Q1
$240K Sell
1,353
-216
-14% -$36.8K 0.09% 162
2021
Q4
$268K Buy
1,569
+110
+8% +$18K 0.07% 160
2021
Q3
$236K Buy
1,459
+89
+6% +$15.2K 0.05% 153
2021
Q2
$226K Buy
+1,370
New +$227K 0.04% 173
2021
Q1
Sell
-1,080
Closed -$170K 846
2020
Q4
$170K Buy
+1,080
New +$159K 0.01% 67

Other funds holding JNJ

Vantage Consulting Group's JNJ Position: Q3 2024 in Review

Vantage Consulting Group sold out of Johnson & Johnson (JNJ) in Q3 2024, closing a stake of 1,605 shares — an estimated $235K sold.

Vantage Consulting Group first reported a position in JNJ in Q4 2020 and held it in 14 quarters. The position peaked at $268K in Q4 2021. 3,882 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • Vantage Consulting Group reported no remaining Johnson & Johnson position as of Q3 2024 after selling out during the quarter.
  • Vantage Consulting Group sold 1,605 Johnson & Johnson shares in Q3 2024, an estimated $235K.
  • Vantage Consulting Group first reported a position in Johnson & Johnson in Q4 2020 and held it in 14 quarters.
  • Vantage Consulting Group's Johnson & Johnson position peaked at $268K in Q4 2021.
  • 3,882 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Vantage Consulting Group's 13F filing for Q3 2024, filed 14 Nov 2024.